Tezepelumab is a human monoclonal antibody (mAb) developed by AstraZeneca and Amgen that targets a protein called thymic stromal lymphopoietin (TSLP). TSLP is a cytokine that has been found to be involved in the development and exacerbation of asthma, atopic dermatitis and other allergic diseases. Tezepelumab has been shown to be effective in reducing symptoms and improving lung function in patients with asthma. In addition, it has been found to be safe and well-tolerated. Tezepelumab is currently undergoing clinical trials for the treatment of asthma and atopic dermatitis.
Tezepelumab, sold under the brand name Tezspire, is a medication specifically designed for severe asthma treatment. Here's a breakdown of its key aspects:
Function:
- Tezepelumab is a human monoclonal antibody. This means it's a lab-made protein designed to target a specific molecule in the body.
- In this case, Tezepelumab targets thymic stromal lymphopoietin (TSLP), an epithelial cell protein that contributes to airway inflammation in asthma.
- By blocking TSLP, Tezepelumab helps reduce inflammation in the airways, easing asthma symptoms.
Applications:
- Tezepelumab is approved for add-on maintenance treatment in adults and children aged 12 years and above with severe asthma.
- This means it's used alongside other existing asthma medications for those whose asthma remains uncontrolled despite current treatments.
Mechanism:
- Tezepelumab binds to TSLP, preventing it from interacting with its receptor on inflammatory cells.
- This disrupts the inflammatory pathway triggered by TSLP, leading to reduced inflammation in the airways.
Benefits:
- Tezepelumab has been shown to significantly reduce asthma exacerbation rates, which are flare-ups of asthma symptoms requiring stronger medical intervention.
- This benefit applies to a broad range of severe asthma patients, regardless of specific asthma subtypes or inflammatory markers.
Important Points:
- Tezepelumab is a relatively new medication (FDA approved in December 2021).
- As with any medication, consult a healthcare professional before starting Tezepelumab to discuss its suitability for your specific case and potential side effects.